Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 48,868 | 43,562 | 35,578 | 30,475 | 15,286 |
| Cost of Goods | 2,153 | 2,455 | 2,135 | 2,224 | 2,263 |
| Gross Profit | 46,715 | 41,107 | 33,443 | 28,251 | 13,023 |
| Operating Expenses | 101,687 | 111,571 | 99,222 | 96,511 | 102,007 |
| Operating Income | -54,819 | -70,009 | -65,644 | -68,036 | -88,721 |
| Other Income | 1,170 | 1,107 | 1,063 | 993 | 963 |
| Pre-tax Income | -53,649 | -68,902 | -64,581 | -67,043 | -87,758 |
| Income Tax | 647 | -31 | 667 | 398 | 85 |
| Net Income Continuous | -54,296 | -68,871 | -65,248 | -67,441 | -87,843 |
| Net Income | $-54,296 | $-68,871 | $-65,248 | $-67,441 | $-87,843 |
| EPS Basic Total Ops | -0.44 | -0.56 | -0.53 | -0.55 | -0.72 |
| EPS Basic Continuous Ops | -0.44 | -0.55 | -0.53 | -0.55 | -0.72 |
| EPS Diluted Total Ops | -0.44 | -0.56 | -0.53 | -0.55 | -0.72 |
| EPS Diluted Continuous Ops | -0.44 | -0.55 | -0.53 | -0.55 | -0.72 |
| EBITDA(a) | $-54,233 | $-69,461 | $-64,788 | $-67,544 | $-88,195 |